Ardian reinvests in Neopharmed Gentili alongside NB Renaissance
Ardian has reinvested in Neopharmed Gentili, following up on its acquisition of a majority stake in 2018. New partner NB Renaissance will also invest, and jointly hold a majority stake with equal shares.